BOSTON--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) (the Company) today announced that Brad Mason has been named as President of Blackstone Medical, Inc. (Blackstone), the Company’s spine implant and biologic subsidiary. Mr. Mason was also recently appointed to the newly created position of Group President, North America at Orthofix, and will continue in that role. He was previously the President of Breg, the Company’s sports medicine subsidiary. Oliver Burckhardt, the previous President of Blackstone, will be leaving Orthofix to pursue other opportunities.
